Kimura Amanda, Bell-Brown Ari, Akinsoto Nkem, Wood Jerry, Peck Amy, Fang Victoria, Issaka Rachel B
Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Center, Seattle, Washington.
UW Medicine Primary Care and Population Health, University of Washington, Seattle, Washington.
AJPM Focus. 2024 Jan 7;3(2):100188. doi: 10.1016/j.focus.2024.100188. eCollection 2024 Apr.
The effectiveness of mailed fecal immunochemical test outreach might be enhanced through an organized colorectal cancer screening program, yet published real-world experiences are limited. We synthesized the process of implementing a colorectal cancer screening program that used mailed fecal immunochemical test outreach in a large integrated academic-community practice.
Data from a pilot mailed fecal immunochemical test program were shared with healthcare system leadership, which inspired the creation of a cross-institutional organized colorectal cancer screening program. In partnership with a centralized population health team and primary care, we defined (1) the institutional approach to colorectal cancer screening, (2) the target population and method for screening, (3) the team responsible for implementation, (4) the healthcare team responsible for decisions and care, (5) a quality assurance structure, and (6) a method for identifying cancer occurrence.
The Fred Hutch/UW Medicine Population Health Colorectal Cancer Screening Program began in September 2021. The workflow for mailed fecal immunochemical test outreach included a mailed postcard, a MyChart message from the patient's primary care provider, a fecal immunochemical test kit with a letter signed by the primary care provider and program director, and up to 3 biweekly reminders. Patients without a colonoscopy 3 months after an abnormal fecal immunochemical test result received navigation through the program. In the first program year, we identified 9,719 patients eligible for outreach, and in an intention-to-treat analysis, 32% of patients completed colorectal cancer screening by fecal immunochemical test or colonoscopy.
Real-world experiences detailing how to implement organized colorectal cancer screening programs might increase adoption. In our experience, broadly disseminating pilot data, early institutional support, robust data management, and strong cross-departmental relationships were critical to successfully implementing a colorectal cancer screening program that benefits all patients.
通过有组织的结直肠癌筛查计划,邮寄粪便免疫化学检测外展服务的有效性可能会得到提高,但已发表的实际经验有限。我们总结了在大型综合学术-社区实践中实施使用邮寄粪便免疫化学检测外展服务的结直肠癌筛查计划的过程。
将一项粪便免疫化学检测试点计划的数据与医疗系统领导层分享,这促使创建了一个跨机构的有组织的结直肠癌筛查计划。我们与一个集中的人群健康团队和初级保健部门合作,确定了:(1)结直肠癌筛查的机构方法;(2)筛查的目标人群和方法;(3)负责实施的团队;(4)负责决策和护理的医疗团队;(5)质量保证结构;(6)识别癌症发生情况的方法。
弗雷德·哈钦森癌症研究中心/华盛顿大学医学部人群健康结直肠癌筛查计划于2021年9月启动。邮寄粪便免疫化学检测外展服务的工作流程包括邮寄明信片、患者初级保健提供者发送的MyChart消息、带有初级保健提供者和项目主任签名信件的粪便免疫化学检测试剂盒,以及最多3次每两周一次的提醒。粪便免疫化学检测结果异常3个月后未进行结肠镜检查的患者可通过该计划获得引导。在该计划的第一年,我们确定了9719名符合外展服务条件的患者,在意向性分析中,32%的患者通过粪便免疫化学检测或结肠镜检查完成了结直肠癌筛查。
详细说明如何实施有组织的结直肠癌筛查计划的实际经验可能会提高其采用率。根据我们的经验,广泛传播试点数据、早期机构支持、强大的数据管理以及牢固的跨部门关系对于成功实施使所有患者受益的结直肠癌筛查计划至关重要。